サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1671091

間葉系幹細胞の世界市場：市場規模・シェア・動向、業界分析 (製品・サービス別、ワークフロー別、種類別、用途別、地域別)、将来予測 (2025年～2034年)

Mesenchymal Stem Cells Market Size, Share, Trends, Industry Analysis Report: By Products and Services, Workflow, Type, Application, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 119 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
間葉系幹細胞の世界市場：市場規模・シェア・動向、業界分析 (製品・サービス別、ワークフロー別、種類別、用途別、地域別)、将来予測 (2025年～2034年)
出版日: 2025年02月01日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、間葉系幹細胞の市場規模は2034年までに112億6,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

間葉系幹細胞 (MSC) は多能性幹細胞の一種で、骨細胞・軟骨細胞・脂肪細胞など様々な種類の細胞に分化することができます。主に骨髄、脂肪組織、臍帯などの組織に存在し、その再生特性で知られています。

間葉系幹細胞 (MSC) 市場は、再生医療に対する需要の増加や、変形性関節症、心血管疾患、自己免疫疾患などの様々な慢性疾患の治療におけるMSCの応用拡大により、大きな成長を遂げています。主な促進要因としては、拡張性を高め生産コストを削減するバイオ製造技術の進歩や、幹細胞研究への投資の拡大が挙げられます。また、個別化医療の導入が進み、MSCを用いた治療法を模索する臨床試験が増加していることも市場を後押ししています。

既製のソリューションを提供する同種MSC製品へのシフトや、創薬や毒性試験への統合といった動向が市場を形成しています。MSCの分化プロトコルの改善、臨床応用の拡大、規制当局の承認を加速するための戦略的パートナーシップの構築などに機会が存在します。研究が進むにつれ、MSC市場は成長を続け、MSCを用いた治療法は臨床と商業の両面で広く受け入れられるようになると予想されます。

間葉系幹細胞市場：分析概要

細胞・細胞株セグメントは間葉系幹細胞市場で最大のシェアを占めていますが、これは臨床・研究用途、特に再生医療や幹細胞を用いた治療におけるMSCの需要が増加しているためです。また、消耗品セグメントは、MSCの培養・拡大プロセスにおける試薬や培地の使用の増加により、最も速い成長を記録しています。

培養・凍結保存セグメントは、臨床応用における長期使用のためにMSCを保存するために不可欠であるため、市場を独占しています。また、分化プロトコルの進歩により、組織再生や治療開発におけるMSCの用途が拡大していることから、分化セグメントも最も急速に成長しています。

自家MSCセグメントは、個別化治療における利点と免疫拒絶反応の減少により、最大の市場シェアを占めています。同種異形MSCセグメントは、より幅広い患者集団のための既製ですぐに使用できるMSC治療への需要の増加により、最も速い成長を遂げています。

MSCは疾患モデリングや新薬候補のスクリーニングに広く使用されているため、薬剤開発・象薬分野はシェアで市場をリードしています。組織工学分野は、再生医療におけるイノベーションと臓器・組織修復におけるMSCの可能性に後押しされ、最も急速に成長しています。

北米が最大の市場シェアを占めていますが、これは先進的な医療インフラ、多額の研究資金、MSCを用いた治療法に対する規制当局の支援によるものです。アジア太平洋もまた、医療、研究、MSCベースの治療応用への投資の増加に支えられ、最も急速に成長している地域です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 間葉系幹細胞市場の洞察

  • 市場スナップショット
  • 間葉系幹細胞の市場力学
    • 促進要因と機会
      • 間葉系幹細胞の利点に対する認識の高まりが、間葉系幹細胞市場を牽引しています。
      • 世界料理やフュージョン料理の人気の高まりが、間葉系幹細胞市場を推進しています。
    • 抑制要因と課題
      • 製品の限界価格の高さや、未開拓市場における製品普及率の低さが世界市場の妨げとなっています。
  • PESTLE分析
  • 間葉系幹細胞市場の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の間葉系幹細胞市場：製品・サービス別

  • 主な分析結果
  • イントロダクション
  • 細胞と細胞株
  • 消耗品
  • サービス

第6章 世界の間葉系幹細胞市場：ワークフロー別

  • 主な分析結果
  • イントロダクション
  • 細胞の調達・分離
  • 培養・凍結保存
  • 差別化
  • 特徴づけ

第7章 世界の間葉系幹細胞市場：種類別

  • 主な分析結果
  • イントロダクション
  • 自家移植
  • 同種異系

第8章 世界の間葉系幹細胞市場：用途別

  • 主な分析結果
  • イントロダクション
  • 疾患モデル
  • 薬剤開発・創薬
  • 幹細胞バンキング
  • 組織工学
  • 毒性学研究
  • その他

第9章 世界の間葉系幹細胞市場：地域別

  • 主な分析結果
  • イントロダクション
    • 間葉系幹細胞市場の評価：地域別 (2020～2034年)
  • 北米
    • 北米：製品・サービス別 (2020～2034年)
    • 北米：ワークフロー別 (2020～2034年)
    • 北米：種類別 (2020～2034年)
    • 北米：用途別 (2020～2034年)
    • 米国
    • カナダ
  • 欧州
    • 欧州：製品・サービス別 (2020～2034年)
    • 欧州：ワークフロー別 (2020～2034年)
    • 欧州：種類別 (2020～2034年)
    • 欧州：用途別 (2020～2034年)
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：製品・サービス別、2020年～2034年
    • アジア太平洋：ワークフロー別 (2020～2034年)
    • アジア太平洋：種類別 (2020～2034年)
    • アジア太平洋：用途別 (2020～2034年)
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：製品・サービス別 (2020～2034年)
    • 中東・アフリカ：ワークフロー別 (2020～2034年)
    • 中東・アフリカ：種類別 (2020～2034年)
    • 中東・アフリカ：用途別 (2020～2034年)
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：製品・サービス別 (2020～2034年)
    • ラテンアメリカ：ワークフロー別 (2020～2034年)
    • ラテンアメリカ：種類別 (2020～2034年)
    • ラテンアメリカ：用途別 (2020～2034年)
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第10章 競合情勢

  • 事業拡大・企業買収の分析
    • 事業拡大
    • 企業買収
  • 提携/協業/合意/公開

第11章 企業プロファイル

  • Thermo Fisher Scientific
  • Lonza Group
  • Merck KGaA
  • Bio-Techne Corporation
  • Stemcell Technologies
  • Cellular Dynamics International
  • Miltenyi Biotec
  • Osiris Therapeutics
  • AlloSource
  • ReNeuron
  • EMD Millipore
  • Astellas Pharma
  • Kite Pharma
  • Celyad
  • Mesoblast
図表

List of Tables:

  • Table 1 Global Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 2 Global Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 3 Global Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 4 Global Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 5 North America: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 6 North America: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 7 North America: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 8 North America: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 10 U.S.: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 11 U.S.: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 12 U.S.: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 13 Canada: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 14 Canada: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 15 Canada: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 16 Canada: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 17 Europe: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 18 Europe: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 19 Europe: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 20 Europe: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 21 UK: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 22 UK: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 23 UK: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 24 UK: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 25 France: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 26 France: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 27 France: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 28 France: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 29 Germany: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 30 Germany: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 31 Germany: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Germany: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Italy: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 34 Italy: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 35 Italy: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 36 Italy: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 37 Spain: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 38 Spain: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 39 Spain: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 40 Spain: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 45 Russia: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 46 Russia: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 47 Russia: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 48 Russia: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 57 China: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 58 China: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 59 China: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 60 China: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 61 India: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 62 India: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 63 India: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 64 India: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Japan: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 70 Japan: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 71 Japan: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 72 Japan: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 77 South Korea: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 78 South Korea: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 79 South Korea: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Korea: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 81 Australia: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 82 Australia: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 83 Australia: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 84 Australia: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 97 UAE: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 98 UAE: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 99 UAE: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 100 UAE: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 101 Israel: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 102 Israel: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 103 Israel: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 104 Israel: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 105 South Africa: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 106 South Africa: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 107 South Africa: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 108 South Africa: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 113 Latin America: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 114 Latin America: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 115 Latin America: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 116 Latin America: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 117 Mexico: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 118 Mexico: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 119 Mexico: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 120 Mexico: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 121 Brazil: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 122 Brazil: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 123 Brazil: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 124 Brazil: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 125 Argentina: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 126 Argentina: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 127 Argentina: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 128 Argentina: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Mesenchymal Stem Cells Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Products and Services
  • Figure 7. Global Mesenchymal Stem Cells Market, by Products and Services, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Workflow
  • Figure 9. Global Mesenchymal Stem Cells Market, by Workflow, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Type
  • Figure 11. Global Mesenchymal Stem Cells Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Application
  • Figure 13. Global Mesenchymal Stem Cells Market, by Application, 2024 & 2034 (USD Billion)
目次
Product Code: PM1565

The mesenchymal stem cells market size is expected to reach USD 11.26 billion by 2034, according to a new study by Polaris Market Research. The report "Mesenchymal Stem Cells Market Size, Share, Trends, Industry Analysis Report: By Products and Services (Cell & Cell Lines, Consumables, and Services), Workflow, Type, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Mesenchymal stem cells (MSCs) are a type of multipotent stem cell that can differentiate into a variety of cell types, including bone cells (osteocytes), cartilage cells (chondrocytes), and fat cells (adipocytes). They are primarily found in tissues such as bone marrow, adipose tissue, and the umbilical cord, and are known for their regenerative properties.

The mesenchymal stem cells (MSCs) market is experiencing significant growth driven by increasing demand for regenerative medicine and the expanding application of MSCs in treating various chronic diseases, including osteoarthritis, cardiovascular conditions, and autoimmune disorders. Key drivers include advancements in biomanufacturing technologies, which enhance scalability and reduce production costs, and growing investments in stem cell research. The market is also being fueled by the rising adoption of personalized medicine and the increasing number of clinical trials exploring MSC-based therapies.

Trends such as the shift toward allogeneic MSC products, which offer off-the-shelf solutions, and their integration into drug discovery and toxicology studies are shaping the market. Opportunities exist in improving MSC differentiation protocols, expanding their clinical applications, and forging strategic partnerships to accelerate regulatory approvals. As research progresses, the MSC market is expected to continue its growth, with MSC-based therapies gaining wider acceptance in both clinical and commercial settings.

Mesenchymal Stem Cells Market Report Highlights

The cell & cell lines segment holds the largest mesenchymal stem cells market share due to the increasing demand for MSCs in clinical and research applications, particularly in regenerative medicine and stem cell-based therapies. The consumables segment is also registering the fastest growth, driven by the increasing use of reagents and media in MSC cultivation and expansion processes.

The culture & cryopreservation segment dominates the market, as it is essential for preserving MSCs for long-term use in clinical applications. The differentiation segment is also growing the fastest, as advancements in differentiation protocols expand MSC applications in tissue regeneration and therapeutic development.

The autologous MSCs segment holds the largest market share due to its advantages in personalized treatments and reduced immune rejection. The allogeneic MSCs segment is experiencing the fastest growth, driven by the increasing demand for off-the-shelf, ready-to-use MSC therapies for broader patient populations.

Drug development & discovery leads the market in terms of share, as MSCs are widely used for disease modeling and screening new drug candidates. The tissue engineering segment is growing the fastest, fueled by innovations in regenerative medicine and the potential of MSCs for organ and tissue repair.

North America holds the largest market share, driven by advanced healthcare infrastructure, significant research funding, and regulatory support for MSC-based therapies. Asia Pacific is also the fastest growing region, supported by increasing investments in healthcare, research, and MSC-based therapeutic applications.

Polaris Market Research has segmented the mesenchymal stem cells market report based on products and services, workflow, type, application, and region:

By Products and Services Outlook (Revenue-USD Billion, 2020 - 2034)

  • Cell & Cell Lines
  • Consumables
  • Services

By Workflow Outlook (Revenue-USD Billion, 2020 - 2034)

  • Cell Sourcing & Isolation
  • Culture & Cryopreservation
  • Differentiation
  • Characterization

By Type Outlook (Revenue-USD Billion, 2020 - 2034)

  • Autologous
  • Allogeneic

By Application Outlook (Revenue-USD Billion, 2020 - 2034)

  • Disease Modeling
  • Drug Development & Discovery
  • Stem Cell Banking
  • Tissue Engineering
  • Toxicology Studies
  • Others

By Regional Outlook (Revenue-USD Billion, 2020 - 2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Mesenchymal Stem Cells Market Insights

  • 4.1. Mesenchymal Stem Cells Market - Market Snapshot
  • 4.2. Mesenchymal Stem Cells Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased awareness of the benefits of Mesenchymal Stem Cells is driving the Mesenchymal Stem Cells market.
      • 4.2.1.2. Rising popularity of global and fusion cuisines Is propelling the Mesenchymal Stem Cells market.
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The high marginal price of the product and lower product penetration in untapped markets are hampering the global market.
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Mesenchymal Stem Cells Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Mesenchymal Stem Cells Market, by Products and Services

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
  • 5.3. Cell & Cell Lines
    • 5.3.1. Global Mesenchymal Stem Cells Market, by Cell & Cell Lines, by Region, 2020-2034 (USD Billion)
  • 5.4. Consumables
    • 5.4.1. Global Mesenchymal Stem Cells Market, by Consumables, by Region, 2020-2034 (USD Billion)
  • 5.5. Services
    • 5.5.1. Global Mesenchymal Stem Cells Market, by Services, by Region, 2020-2034 (USD Billion)

6. Global Mesenchymal Stem Cells Market, by Workflow

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
  • 6.3. Cell Sourcing & Isolation
    • 6.3.1. Global Mesenchymal Stem Cells Market, by Cell Sourcing & Isolation, by Region, 2020-2034 (USD Billion)
  • 6.4. Culture & Cryopreservation
    • 6.4.1. Global Mesenchymal Stem Cells Market, by Culture & Cryopreservation, by Region, 2020-2034 (USD Billion)
  • 6.5. Differentiation
    • 6.5.1. Global Mesenchymal Stem Cells Market, by Differentiation, by Region, 2020-2034 (USD Billion)
  • 6.6. Characterization
    • 6.6.1. Global Mesenchymal Stem Cells Market, by Characterization, by Region, 2020-2034 (USD Billion)

7. Global Mesenchymal Stem Cells Market, by Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
  • 7.3. Autologous
    • 7.3.1. Global Mesenchymal Stem Cells Market, by Autologous, by Region, 2020-2034 (USD Billion)
  • 7.4. Allogeneic
    • 7.4.1. Global Mesenchymal Stem Cells Market, by Allogeneic, by Region, 2020-2034 (USD Billion)

8. Global Mesenchymal Stem Cells Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • 8.3. Disease Modeling
    • 8.3.1. Global Mesenchymal Stem Cells Market, by Disease Modeling, by Region, 2020-2034 (USD Billion)
  • 8.4. Drug Development & Discovery
    • 8.4.1. Global Mesenchymal Stem Cells Market, by Drug Development & Discovery, by Region, 2020-2034 (USD Billion)
  • 8.5. Stem Cell Banking
    • 8.5.1. Global Mesenchymal Stem Cells Market, by Stem Cell Banking, by Region, 2020-2034 (USD Billion)
  • 8.6. Tissue Engineering
    • 8.6.1. Global Mesenchymal Stem Cells Market, by Tissue Engineering, by Region, 2020-2034 (USD Billion)
  • 8.7. Toxicology Studies
    • 8.7.1. Global Mesenchymal Stem Cells Market, by Toxicology Studies, by Region, 2020-2034 (USD Billion)
  • 8.8. Others
    • 8.8.1. Global Mesenchymal Stem Cells Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Mesenchymal Stem Cells Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Mesenchymal Stem Cells Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Mesenchymal Stem Cells Market - North America
    • 9.3.1. North America: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
    • 9.3.2. North America: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
    • 9.3.3. North America: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
    • 9.3.4. North America: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.3.5. Mesenchymal Stem Cells Market - US
      • 9.3.5.1. US: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.3.6. Mesenchymal Stem Cells Market - Canada
      • 9.3.6.1. Canada: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • 9.4. Mesenchymal Stem Cells Market - Europe
    • 9.4.1. Europe: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.4.5. Mesenchymal Stem Cells Market - UK
      • 9.4.5.1. UK: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.4.6. Mesenchymal Stem Cells Market - France
      • 9.4.6.1. France: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.4.7. Mesenchymal Stem Cells Market - Germany
      • 9.4.7.1. Germany: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.4.8. Mesenchymal Stem Cells Market - Italy
      • 9.4.8.1. Italy: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.4.9. Mesenchymal Stem Cells Market - Spain
      • 9.4.9.1. Spain: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.4.10. Mesenchymal Stem Cells Market - Netherlands
      • 9.4.10.1. Netherlands: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.4.11. Mesenchymal Stem Cells Market - Russia
      • 9.4.11.1. Russia: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.4.12. Mesenchymal Stem Cells Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • 9.5. Mesenchymal Stem Cells Market - Asia Pacific
    • 9.5.1. Asia Pacific: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.5.5. Mesenchymal Stem Cells Market - China
      • 9.5.5.1. China: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.5.6. Mesenchymal Stem Cells Market - India
      • 9.5.6.1. India: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.5.7. Mesenchymal Stem Cells Market - Malaysia
      • 9.5.7.1. Malaysia: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.5.8. Mesenchymal Stem Cells Market - Japan
      • 9.5.8.1. Japan: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.5.9. Mesenchymal Stem Cells Market - Indonesia
      • 9.5.9.1. Indonesia: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.5.10. Mesenchymal Stem Cells Market - South Korea
      • 9.5.10.1. South Korea: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.5.11. Mesenchymal Stem Cells Market - Australia
      • 9.5.11.1. Australia: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.5.12. Mesenchymal Stem Cells Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • 9.6. Mesenchymal Stem Cells Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.6.5. Mesenchymal Stem Cells Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.6.6. Mesenchymal Stem Cells Market - UAE
      • 9.6.6.1. UAE: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.6.7. Mesenchymal Stem Cells Market - Israel
      • 9.6.7.1. Israel: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.6.8. Mesenchymal Stem Cells Market - South Africa
      • 9.6.8.1. South Africa: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.6.9. Mesenchymal Stem Cells Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
  • 9.7. Mesenchymal Stem Cells Market - Latin America
    • 9.7.1. Latin America: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.7.5. Mesenchymal Stem Cells Market - Mexico
      • 9.7.5.1. Mexico: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.7.6. Mesenchymal Stem Cells Market - Brazil
      • 9.7.6.1. Brazil: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.7.7. Mesenchymal Stem Cells Market - Argentina
      • 9.7.7.1. Argentina: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)
    • 9.7.8. Mesenchymal Stem Cells Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Mesenchymal Stem Cells Market, by Products and Services, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Mesenchymal Stem Cells Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Mesenchymal Stem Cells Market, by Type, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Mesenchymal Stem Cells Market, by Application, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Thermo Fisher Scientific
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Lonza Group
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Merck KGaA
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Bio-Techne Corporation
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Stemcell Technologies
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Cellular Dynamics International
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Miltenyi Biotec
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Osiris Therapeutics
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. AlloSource
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. ReNeuron
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. EMD Millipore
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Astellas Pharma
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Kite Pharma
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Celyad
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Mesoblast
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development